⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
Longevity Startup Initiatives
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-06 — Longevity Is The New Luxury—Inside The $6.8 Trillion Wellness Boom: Forbes positions longevity as the new luxury within a $6.8T wellness economy — trade/business-press signal of capital and consumer-market tailwinds around longevity startups, market-sizing claim only with no company- or product-level data. [expert-opinion] (novelty: 3)
- 2026-10-07 — KHL Foundation Reports the Likely First Human Partial Epigenetic Reprogramming Treatments: KHL Foundation report notes that medical-tourism AAV reprogramming treatments have reportedly been administered before Life Biosciences’ formal optic-neuropathy trial reads out — trade/community-news signal on the gap between sanctioned longevity-biotech pipelines and parallel unregulated use. [anecdotal-biohack] (novelty: 4)
- 2026-09-17 — Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study: Insilico Medicine reports opening its proprietary AI longevity discovery toolkit to outside researchers alongside a Cell cover study — signals a platform-access play by an AI-longevity startup; announcement-level, no data on adoption or output. [expert-opinion] (novelty: 3)
- 2026-09-15 — Insilico Launches AI-driven Longevity Vaccines Research for Aging-related Diseases and Human Longevity: Company press release: Insilico Medicine adds a longevity-vaccines program to its AI-driven pipeline, illustrating startup indication-expansion from AI drug discovery into prophylactic aging shots; announcement-level signal, no data. [expert-opinion] (novelty: 3)
- 2026-07-13 — CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy: cross-connection with gene-therapy-muscle-aging: Dual AAV+plasmid muscle-aging program is the kind of first-in-class trial being seeded by longevity-focused biotech sponsors targeting sarcopenia as an aging indication. (novelty: 4)
- 2026-09-07 — Living longer starts earlier: why longevity is becoming a megatrend: 2026 Deutsche Bank commentary frames longevity as an emerging megatrend and argues action should start earlier in life; institutional-finance mainstreaming signal, headline-level only with no primary data. [expert-opinion] (novelty: 3)
- 2026-09-07 — Insilico’s IPF candidate rentosertib shows anti-aging promise: Trade-press coverage highlights Insilico Medicine (AI drug-discovery startup) advancing rentosertib from IPF indication into an anti-aging positioning; startup-narrative signal about indication-expansion strategy, no primary readout attached. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Liflex raises $5.25M Series A for anti-aging RNA therapies
13-nov-2026
novelty 2
per-area 2
mentions
Tiny Health launches a biological age score for the gut
12-nov-2026
novelty 3
per-area 2
mentions
Longevity sector ambitions outpace regulatory and investment frameworks
11-nov-2026
novelty 2
per-area 2
mentions
Bioscope.ai Advances Personalized Longevity Medicine Through New Partnerships and Platform Growth
10-nov-2026
novelty 2
per-area 2
mentions
Longevity Innovation Canada: 3 Ageing Population Solutions
09-nov-2026
novelty 2
per-area 2
mentions
What’s Next Longevity Innovation Summit
09-nov-2026
novelty 1
per-area 1
mentions
KHL Foundation Reports the Likely First Human Partial Epigenetic Reprogramming Treatments
07-oct-2026
novelty 4
per-area 4
strengthens
Longevity Is The New Luxury—Inside The $6.8 Trillion Wellness Boom
06-oct-2026
novelty 3
per-area 3
strengthens
Rejuvenation Roundup September 2026
01-oct-2026
novelty 1
per-area 1
mentions
Advancing aging biomarkers and intervention discovery at the TimePie Longevity Forum.
30-sep-2026
novelty 2
per-area 2
mentions
The startup trap that kept this longevity app founder stuck
27-sep-2026
novelty 1
per-area 1
mentions
Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa
25-sep-2026
novelty 2
per-area 2
strengthens
Wei-Wu He: Craig Venter’s Legacy and the Future of Human Longevity
23-sep-2026
novelty 2
per-area 2
mentions
Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
17-sep-2026
novelty 3
per-area 3
strengthens
Insilico Launches AI-driven Longevity Vaccines Research for Aging-related Diseases and Human Longevity
15-sep-2026
novelty 3
per-area 3
strengthens
Fight Aging! Newsletter, September 14th 2026
13-sep-2026
novelty 2
per-area 2
mentions
AI-designed drug could slow aging; chatbots abandon referral advice when patients push back; virtual reality helped anxious patients finish cardiac scans — Morning Medical Update
09-sep-2026
novelty 2
per-area 2
mentions
Healthspan Innovators: Deadline approaching for longevity start-up initiative
09-sep-2026
novelty 2
per-area 2
mentions
Lone Korean biotech nears $81m antiaging prize
08-sep-2026
novelty 2
per-area 2
mentions
Living longer starts earlier: why longevity is becoming a megatrend
07-sep-2026
novelty 3
per-area 3
strengthens
Insilico's IPF candidate rentosertib shows anti-aging promise
07-sep-2026
novelty 3
per-area 3
strengthens